Autophagy as a target for development of anti-diabetes drugs derived from natural compounds
Autophagy as a target for development of anti-diabetes drugs derived from natural compounds
复制标题
自噬作为开发天然化合物抗糖尿病药物的目标
DOI:
10.1080/10286020.2017.1304929
复制
发表时间:
2017-03
影响因子:
1.7
通讯作者:
Hu Zhuo-Wei
中科院分区:
文献类型:
--
作者:
Zhang Xiao-Wei;Zhou Ji-Chao;Hu Zhuo-Wei
Abstract Patients with diabetes have a high level of blood glucose because their body cannot produce enough insulin or properly respond to this hormone. In both situations, it has become evident that persistent high concentrations of glucose, insulin, insulin-like growth factor, and insulin resistance lead to dysfunction and destruction of autophagic activity in the cells of islet and other organs involved in complications of diabetes, including the liver, cardiovascular, and nervous systems. Accumulating evidences have revealed that autophagy is a novel therapeutic target with a wide range of beneficial effects on diabetes and that plenty of drugs and natural products are involved in autophagy modulation, either inducing or inhibiting autophagy, through multiple signaling pathways. In this review, we summarize the roles of several clinical drugs and compounds derived from natural products in diabetes and its complications through regulation of autophagy, expecting to inspire further investigation of the underlying mechanisms of these compounds and to facilitate their better clinical application.
登录
查看更多内容
影响因子:
7.7
作者:
Hardie DG
通讯作者:
Hardie DG
影响因子:
21.3
作者:
通讯作者:
--
影响因子:
4.8
作者:
Pacholec, Michelle;Bleasdale, John E.;Ahn, Kay
通讯作者:
Ahn, Kay
DOI:
10.1016/b978-0-12-803783-6.00006-7
发表时间:
2017-01-01
期刊:
PARKINSON'S DISEASE: MOLECULAR MECHANISMS UNDERLYING PATHOLOGY
影响因子:
--
作者:
Lewis, P. A.;Perez-Carrion, M.;Piccoli, G.
通讯作者:
Piccoli, G.
影响因子:
64.8
作者:
J. Galton
通讯作者:
J. Galton